Skip to content

Mannkind MNKD Non-cash interest expense

Non-cash interest expense at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
Merit Medical Systems logo
Merit Medical SystemsMMSI

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's non-cash interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's non-cash interest expense?
Mannkind (MNKD) reported non-cash interest expense of $452K in Q1 2026.
How has Mannkind's non-cash interest expense changed year-over-year?
Mannkind's non-cash interest expense increased by 314.7% year-over-year, from $109K to $452K.
What is the long-term trend for Mannkind's non-cash interest expense?
Over 4 years (2021 to 2025), Mannkind's non-cash interest expense has grown at a -15.9% compound annual growth rate (CAGR), from $1.71M to $854K.